HIV-1 diagnostic, prognostic and ART-resistance detection potential of selected MiRNAs
Abstract Background The global HIV prevalence estimate at the end of 2022 was 39 million. This has led to mass testing to diagnose new cases, and the conduction of prognostic tests for monitoring HIV progression. This is being done to meet the targets of the 95%: 95%: 95% UN AIDS goal which is to be...
| Published in: | BMC Infectious Diseases |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-06-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12879-025-11135-7 |
